Market Overview

Cardiac Pacemakers Market Will Reach US$ 5,131.9 Mn by 2026, Medtronic's Launch App-Integrated Pacemakers to Aid Overall Expansion, says Fortune Business Insights


Pune, July 01, 2019 (GLOBE NEWSWIRE) -- The global Cardiac Pacemakers Market is likely to grow in the coming years due to an increasing cases of sudden cardiac deaths. According to a report published by Fortune Business Insights, titled "Cardiac Pacemakers Market: Global Market Analysis, Insights and Forecast, 2019-2026," the market was valued at US$ 4,064.9 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 5,131.9 Mn by the end of 2026, thereby exhibiting a CAGR of 3.0%.

Medtronic and Boston Scientific Corporation to Account for More Than Half of the Market Share in Terms of Revenue
Cardiac Resynchronization Therapy Device Pacemaker (CRT-P) is expected to register significant growth over the forecast period

The cardiac pacemakers have gained popularity in recent times due to their application in monitoring patient heartbeat using electrical stimulation. Cardiac Pacemakers have the ability to operate over a short or longer period of time, depending upon the application. The ability of cardiac pacemakers to provide diagnostic information about the heart has led to a rise in uptake of the device, globally.

Browse Complete Report Details with Tables of Content and Figures:

Technological Advancements Witnessed in the Market to Support Growth

The advancements in pacemakers have been noteworthy due to the ease of use and comfort that they have brought. The report includes various technological advancements with regard to pacemakers that have contributed positively to the overall market. The introduction of technologically sound pacemakers has created a surge in demand. This, in turn, has created an emphasis on research and development of newer products. IN 2019, Medtronic announced that it plans to launch an application that would be integrated with its line of pacemakers. The use of application-integrated cardiac pacemakers will enable features such as ease of use, constant alerts, and early diagnosis. The company announced the MyCareLink Heart mobile app that would be integrated with the company's BlueSync technology. The report stresses on product launches integrated with newer technologies and gauges the impact that these products have on the global Cardiac Pacemakers Market.

Increasing Regulatory Approvals are Favoring Expansion

The cardiac pacemakers are sensitive devices that need usage approvals before being commercialized. In such scenarios, increasing approvals will enable growth of the global market. Recently, the Food and Drug Administration (FDA) has eased off on its approval of cardiac treatment devices. Growing FDA approvals have encouraged companies to come up products of their own. One such healthcare company, ‘Boston Scientific' boasts several FDA approved devices aimed at treatment of cardiac disorders. Recently, Boston Scientific gained approval for its Ingenio and Advantio pacemakers. The devices were launched to match the heartbeats of related patients with a few precise activities.

Sample PDF

The Ingenio offers respiratory rate trend (RRT), a feature used to monitor respiratory activities. The device was designed to examine heart failure diagnostics and subsequently improve patient outcome. Boston's cardiac pacemakers will boost the global Cardiac Pacemakers Market and will enable growth of the market in the forthcoming years.

Fortune Business Insights has profiled some of the leading companies that have made significant growth contributions to the global market. The report gauges the impact of these companies on the global market. Some of the leading companies include Medtronic, Boston Scientific Corporation, Biotronik, LivaNova Plc, Abbott and Microport.

Key companies covered in the report

  • Medtronic Plc
  • Boston Scientific Corporation
  • Biotronik
  • LivaNova Plc
  • Abbott
  • Microport
  • Other prominent players

Speak to Analyst

Table of Content:

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities

  • Key Insights
    • Prevalence of Sudden Cardiac Arrests in Key Countries
    • Technological Advancements in Cardiac Pacemakers
    • Recent Industry Developments Such as Mergers & Acquisitions
    • The Regulatory Scenario in Key Countries
    • New Product Launches by key Players

  • Global Cardiac Pacemaker Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary

    • Market Analysis, Insights and Forecast – By Product
      • Single Chamber Cardiac Pacemaker
      • Dual Chamber Cardiac Pacemaker
      • Cardiac Re-synchronization Therapy Pacemaker (CRT-P)

    • Market Analysis, Insights and Forecast – By End User
      • Hospitals
      • Ambulatory Surgery Centers and Others

    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Rest of the World
  •  Competitive Analysis   
  • Strategic Recommendations    

Request for Customization:

Browse Related Reports:

  • Cardiac Rhythm Management Devices Market Size, Share and Global Trend Product By (Cardiac Pacemakers, Defibrillators, Cardiac Resynchronization Therapy Devices) By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and Geography Forecast to 2026
  • Cardiovascular Stents Market Size, Share and Global Trend By Product Type (Coronary Stenting, Peripheral Stenting), Stent Type (Drug Eluting Stents (DES), Bioresorbable Stents, Bare Metal Stents & Others), Disease Indication (Venous Disease, Arterial Disease), End User and Geography Forecast by 2025

  • Coronary Stents Market Size, Share and Global Trend By Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Catheterization Labs) and Geography Forecast till 2025

  • Orphan Drugs Market Size, Share and Global Trend By Therapy Area (Oncology, Blood, CNS, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) and Geography Forecast till 2025

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:

Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245



View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at